Non-Exclusive Patent License Agreement Sample Contracts

KokiCare, Inc. – Non-Exclusive Patent License Agreement (May 2nd, 2017)

This NON-EXCLUSIVE PATENT LICENSE AGREEMENT (this "Agreement") is made as of October 22, 2013 (the "Effective Date") by and between Advanced Inhalation Therapies (AIT) Ltd., a company incorporated under the laws of the State of Israel ("Licensee"), and SensorMedics Corporation, a California corporation ("CareFusion").

KokiCare, Inc. – Non-Exclusive Patent License Agreement (March 15th, 2017)

This NON-EXCLUSIVE PATENT LICENSE AGREEMENT (this "Agreement") is made as of October 22, 2013 (the "Effective Date") by and between Advanced Inhalation Therapies (AIT) Ltd., a company incorporated under the laws of the State of Israel ("Licensee"), and SensorMedics Corporation, a California corporation ("CareFusion").

KokiCare, Inc. – Non-Exclusive Patent License Agreement (January 20th, 2017)

This NON-EXCLUSIVE PATENT LICENSE AGREEMENT (this "Agreement") is made as of October 22, 2013 (the "Effective Date") by and between Advanced Inhalation Therapies (AIT) Ltd., a company incorporated under the laws of the State of Israel ("Licensee"), and SensorMedics Corporation, a California corporation ("CareFusion").

Kadmon Holdings, LLC – Non-Exclusive Patent License Agreement (June 10th, 2016)

THIS NON-EXCLUSIVE PATENT LICENSE AGREEMENT (this Agreement) is made and entered into as of June 20, 2008 (Effective Date) by and among Three Rivers Pharmaceuticals LLC, a Pennsylvania limited liability company, (the Licensor), Zydus Pharmaceuticals USA, Inc., a New Jersey corporation, and Cadila Healthcare Limited d/b/a Zydus-Cadila, an Indian corporation (collectively, the Licensee), Licensor and Licensee are sometimes referred to as the Parties and individually as a Party.

Kadmon Holdings, LLC – Non-Exclusive Patent License Agreement (March 18th, 2016)

THIS NON-EXCLUSIVE PATENT LICENSE AGREEMENT (this Agreement) is made and entered into as of June 20, 2008 (Effective Date) by and among Three Rivers Pharmaceuticals LLC, a Pennsylvania limited liability company, (the Licensor), Zydus Pharmaceuticals USA, Inc., a New Jersey corporation, and Cadila Healthcare Limited d/b/a Zydus-Cadila, an Indian corporation (collectively, the Licensee), Licensor and Licensee are sometimes referred to as the Parties and individually as a Party.

Advanced Inhalation Therapies (AIT) Ltd. – Non-Exclusive Patent License Agreement (November 3rd, 2015)

This NON-EXCLUSIVE PATENT LICENSE AGREEMENT (this "Agreement") is made as of October 22, 2013 (the "Effective Date") by and between Advanced Inhalation Therapies (AIT) Ltd., a company incorporated under the laws of the State of Israel ("Licensee"), and SensorMedics Corporation, a California corporation ("CareFusion").

Advanced Inhalation Therapies (AIT) Ltd. – Non-Exclusive Patent License Agreement (October 15th, 2015)

This NON-EXCLUSIVE PATENT LICENSE AGREEMENT (this "Agreement") is made as of October 22, 2013 (the "Effective Date") by and between Advanced Inhalation Therapies (AIT) Ltd., a company incorporated under the laws of the State of Israel ("Licensee"), and SensorMedics Corporation, a California corporation ("CareFusion").

Entellus Medical – Amendment Number 1 Confidential Settlement Agreement and Non-Exclusive Patent License Agreement (January 28th, 2015)

This Amendment No. 1 to the Confidential Settlement Agreement and Non-Exclusive Patent License Agreement dated February 17, 2011 by and between Acclarent, Inc. (Acclarent), and Entellus Medical, Inc. (Entellus) (the Agreement) is effective as of this 5th day of October, 2012 (Effective Date).

Entellus Medical – Confidential Settlement Agreement and Non-Exclusive Patent License Agreement (January 15th, 2015)

This Confidential Settlement Agreement and Non-Exclusive Patent license Agreement (Agreement), effective as of this 17 day of February, 2011 (Effective Date), by and between the following parties:

Entellus Medical – Confidential Settlement Agreement and Non-Exclusive Patent License Agreement (October 7th, 2014)

This Confidential Settlement Agreement and Non-Exclusive Patent license Agreement (Agreement), effective as of this 17 day of February, 2011 (Effective Date), by and between the following parties:

Entellus Medical – Amendment Number 1 Confidential Settlement Agreement and Non-Exclusive Patent License Agreement (October 7th, 2014)

This Amendment No. 1 to the Confidential Settlement Agreement and Non-Exclusive Patent License Agreement dated February 17, 2011 by and between Acclarent, Inc. (Acclarent), and Entellus Medical, Inc. (Entellus) (the Agreement) is effective as of this 5th day of October, 2012 (Effective Date).

Advanced Inhalation Therapies (AIT) Ltd. – **Confidential Portions Have Been Omitted Pursuant to a Request for Confidential Treatment and Have Been Filed Separately With the Securities and Exchange Commission (The "Commission").** Non-Exclusive Patent License Agreement (July 30th, 2014)

This NON-EXCLUSIVE PATENT LICENSE AGREEMENT (this "Agreement") is made as of October 22, 2013 (the "Effective Date") by and between Advanced Inhalation Therapies (AIT) Ltd., a company incorporated under the laws of the State of Israel ("Licensee"), and SensorMedics Corporation, a California corporation ("CareFusion").

Iaso Pharma Inc – Non-Exclusive Patent License Agreement (December 27th, 2010)

THIS AGREEMENT, effective as of November 4, 2009 (the Effective Date), by and between Pacific Beach Biosciences, Inc, a corporation organized and existing under the laws of Delaware with its principal offices at 8910 University Center Lane, Suite 620, San Diego, CA 92122 USA (PBBio) and Merck Sharp & Dohme Corp. (Merck).

Iaso Pharma Inc – Non-Exclusive Patent License Agreement (July 9th, 2010)

THIS AGREEMENT, effective as of November 4, 2009 (the Effective Date), by and between Pacific Beach Biosciences, Inc, a corporation organized and existing under the laws of Delaware with its principal offices at 8910 University Center Lane, Suite 620, San Diego, CA 92122 USA (PBBio) and [*].

Non-Exclusive Patent License Agreement Between Osmetech and the University of Washington Uw Reference: 7063-18921a Uw Techtransfer, Invention Licensing Negotiated by Christine Han, PH.D., M.P.H. (May 21st, 2010)

This Agreement (Agreement) is dated and effective as of the date of last signature (the Effective Date), and is made by and between the University of Washington, a public institution of higher education and an agency of the state of Washington (the University), and Osmetech Molecular Diagnostics, an entity consisting solely of Clinical Micro Sensors, Inc. and Osmetech, Inc., both Delaware Corporations (the Company), (individually a Party or collectively the Parties).

Non-Exclusive Patent License Agreement Between Osmetech and the University of Washington Uw Reference: 7063-18921a Uw Techtransfer, Invention Licensing Negotiated by Christine Han, PH.D., M.P.H. (March 19th, 2010)

This Agreement (Agreement) is dated and effective as of the date of last signature (the Effective Date), and is made by and between the University of Washington, a public institution of higher education and an agency of the state of Washington (the University), and Osmetech Molecular Diagnostics, an entity consisting solely of Clinical Micro Sensors, Inc. and Osmetech, Inc., both Delaware Corporations (the Company), (individually a Party or collectively the Parties).

Nastech Pharmaceutical Company, Inc. – Non-Exclusive Patent License Agreement (August 19th, 2009)

THIS NON-EXCLUSIVE PATENT LICENSE AGREEMENT (Agreement), effective as of February 12, 2009 (Effective Date) is by and between, on the one hand, Hoffmann-La Roche Inc. with a place of business at 340 Kingsland Street, Nutley, New Jersey 07110 and F. Hoffmann-La Roche Ltd with a place of business at Grenzacherstrasse 124, 4070 Basel, Switzerland (collectively Roche) and, on the other hand, MDRNA, Inc. with a place of business at 3830 Monte Villa Parkway, Bothell, Washington 98021 (MDRNA). Roche and MDRNA are referred to in this Agreement individually as a Party and collectively as the Parties.

Nastech Pharmaceutical Company, Inc. – Non-Exclusive Patent License Agreement (May 15th, 2009)

THIS NON-EXCLUSIVE PATENT LICENSE AGREEMENT (Agreement), effective as of February 12, 2009 (Effective Date) is by and between, on the one hand, Hoffmann-La Roche Inc. with a place of business at 340 Kingsland Street, Nutley, New Jersey 07110 and F. Hoffmann-La Roche Ltd with a place of business at Grenzacherstrasse 124, 4070 Basel, Switzerland (collectively Roche) and, on the other hand, MDRNA, Inc. with a place of business at 3830 Monte Villa Parkway, Bothell, Washington 98021 (MDRNA). Roche and MDRNA are referred to in this Agreement individually as a Party and collectively as the Parties.

Osmetech PLC – Non-Exclusive Patent License Agreement Between Osmetech and the University of Washington Uw Reference: 7063-18921a Uw Techtransfer, Invention Licensing Negotiated by Christine Han, PH.D., M.P.H. (September 12th, 2008)

This Agreement (Agreement) is dated and effective as of the date of last signature (the Effective Date), and is made by and between the University of Washington, a public institution of higher education and an agency of the state of Washington (the University), and Osmetech Molecular Diagnostics, an entity consisting solely of Clinical Micro Sensors, Inc. and Osmetech, Inc., both Delaware Corporations (the Company), (individually a Party or collectively the Parties).

ImmunoBiotics, Inc. – Non-Exclusive Patent License Agreement (November 28th, 2007)

This Non-exclusive Patent License Agreement entered into this 1st day of September, 2007, by and between ImmunoBiotics, Inc., a corporation organized under the laws of the State of Florida, having its principal office at 511 NE 94th Street, Building 2, MiamiShores, Florida 33138, hereinafter referred to as "Licensor," and SYNORx, Inc., a corporation organized under the laws of the State of Nevada, having its principal office at 1060 Calle Negocio, Suite B, San Clemente, California 92673, hereinafter referred to as "Licensee."

Fp Technology – Non-Exclusive Patent License Agreement (September 28th, 2006)

This Non-Exclusive Patent License Agreement (this Agreement), made and entered into this 28th day of March, 2006 (the Effective Date), by and between Orion IP, LLC (Licensor), a limited liability company organized under the laws of the state of Delaware, and FP Technology Holdings, Inc., a Delaware corporation (Licensee) (each a Party and collectively the Parties).

[NREL National Renewable Energy Laboratory LOGO] NON-EXCLUSIVE PATENT LICENSE AGREEMENT Between Midwest Research Institute and Ascent Solar Technologies, Inc. (April 20th, 2006)

This License Agreement (hereinafter "Agreement") is between Midwest Research Institute (hereinafter "MRI") located at 425 Volker Boulevard, Kansas City, Missouri 64110, Management and Operating Contractor for the National Renewable Energy Laboratory (hereinafter "NREL") located at 1617 Cole Blvd., Golden, Colorado 80401 and Ascent Solar Technologies, Inc., (hereinafter "Licensee"), a Colorado company organized and existing under the laws of the State of Delaware and having a principal place of business at 8120 Shaffer Parkway, Littleton, CO 80127, each hereinafter referred to individually as a "Party" and jointly as "Parties." This Agreement shall be effective on the later of (a) the date the last Party signs this Agreement or (b) the date MRI receives the Upfront Fee pursuant to Section B of Exhibit B hereof (hereinafter "Effective Date").

Non-Exclusive Patent License Agreement (March 29th, 2002)
Dna Plant Technology Corp – Non-Exclusive Patent License Agreement (February 2nd, 1996)